Advertisement

Sialidoses (Mucolipidoses), Clinical Pictures

  • Ulrich N. Wiesmann
  • Norbert Herschkowitz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 125)

Abstract

The mucolipidoses (I,II,III) have been recognized as a separate entity of diseases by Spranger and Wiedemann (1970) who separated them on the basis of biochemical, histological and clinical findings from the group of the mucopolysaccharidoses. Mucolipidosis I was first described in 1968 by Spranger et al. under the name lipomucopolysaccharidosis. The overall clinical picture was that of a Hurler-Hunter phenotype with normal mucopolysacchariduria, a cherry-red macular spot and signs of a neuro-degenerative process involving mainly the white matter (Spranger et al. 1968). Mucolipidosis II is identical with the so called inclusion cell disease (I-cell disease) according to the numerous cytoplasmic inclusions in the cultured fibroblasts of the patients as described by Leroy et al. (1969, 1971). It also is clinically resembling Hurler’s syndrome with a remarkably stunted growth and severe retardation. Mucolipidosis III, formerly named pseudo-hurler polydystrophy by Maroteaux and Lamy (1966) presents clinically with short stature, mild Hurler-like dysmorphism and mental retardation. The term sialidosis was coined by Strecker et al. (1977) in analogy to mannosidosis and fucosidosis. He proposed to call the three types of mucolipidosis (I,II,II) sialidosis I, II, III respectively, in regard to the nature of the enzymatic defect and to the accumulation of sialic acid rich oligosaccharides.

Keywords

Sialic Acid Carpal Tunnel Syndrome Lysosomal Enzyme Cerebellar Ataxia Acid Hydrolase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BERARD M., TOGA M., BERNARD R., DUBOIS D., MARIANI R. and HASSOUN J. (1968): Pathological findings in one case of neuronal and mesenchymal storage disease. Its relationship to lipidoses and to mucopolysaccharidoses. Path. Europ. 3, 1972–183.Google Scholar
  2. BERMAN E.R., KOHN G. and STEIN H. (1974): Acid hydrolase deficiencies and abnormal glycoproteins in mucolipidosis III (Pseudohurlerpolydystrophy). Clin. Chim. Acta 52, 115–124.PubMedCrossRefGoogle Scholar
  3. CANTZ M., GEHLER J. and SPRANGER J. (1977): Mucolipidosis I: increased sialic acid content and deficiency of an Ac-N-acetylneuraminidase in cultured fibroblasts. Biochem. Biophys, Res. Commun. 74, 732–738.CrossRefGoogle Scholar
  4. DOOSE H., SPRANGER J. and WARNER M. (1975): EEG in Mucolipidosis I. Neuropädiatrie 6, 98–101.CrossRefGoogle Scholar
  5. DURAND P., GATTI R., CAVALIERI S., BORRONE C., TONDEUR M., MICHALSKI J.C. and STRECKER G. (1977): Sialidosis (Mucolipidosis I). Helv. Paediat. Acta 32, 391–400.Google Scholar
  6. ENDO H., AL-SAMARRAI S., SAKAKIBARA K., NAGASHIMA K. and SHIMADA Y. (1977): A new type of mucolipidosis associated with hereditary thrombocytopathy and color blindness. Acta Path. Jap. 27, 421–434.PubMedGoogle Scholar
  7. ERICKSON R.P., PFLENGER O.H., SANDMAN R. and HALL B.D. (1975): Placental pathology in Mucolipidosis II. Birth Defects orig. art. series 11, 365.Google Scholar
  8. FARRIAUX J.P., WALBAUM R., HONGRE J.F. and DUBOIS O. (1976): La mucolipidose II on “I-cell disease”. Revue critique de 5 observations personelles. Lille med. 21, 51–70.PubMedGoogle Scholar
  9. GEHLER J., CANTZ M., STOECKENINS M. and SPRANGER J. (1976): Prenatal diagnosis of Mucolipidosis II (I-cell disease). Europ. J. Pediat. 122, 201–206.PubMedCrossRefGoogle Scholar
  10. GLASER J.H., McALISTER W.H. and SLY W.S. (1974): Genetic heterogeneity in multiple lysosomal hydrolase deficiency: Mucolipidosis II and III. J. Ped. 85, 192–198.CrossRefGoogle Scholar
  11. GOLDBERG M.F., COTHIER E., FICHENSCHER L.G., KENYON K., ENAT R., BOROWSKY S.A. (1971): Macular cherry red spot, corneal clouding and galactosidase deficiency. Clinical, biochemical and electronmicroscopic study of a new autosomal recessive storage disease. Arch. Intern. Med. 128, 387–398..Google Scholar
  12. HICKMAN S. and NEUFELD E.F. (1972): A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes. Biochem. Biophys. Res. Commun. 49, 992–999.PubMedCrossRefGoogle Scholar
  13. KELLY T.E., THOMAS G.H., TAYLOR H.A., McKUSICK V.A., SLY W.S., GLASER J.H., ROBINSON M., LUZZATTI L., ESPIRITA C., FEINGOLD M., BULL M.J., SKENHURST E.M. and IVES E.J. (1975): Mucolipidosis III (Pseudo-Hurler Polydystrophy): clinical and laboratory studies in a series of 12 patients. J. Hopkins Med. J. 137, 156–175.Google Scholar
  14. LEROY J.G., DE MARS R.I. and OPITZ J.M. (1969): I-cell disease. Birth Defects, Orig.art. series 4, 174–185.Google Scholar
  15. LEROY J.G., SPRANGER J.W., FEINGOLD M., OPITZ J.M. and CROCKER A.C. (1971): I-cell disease: a clinical picture. J. Pediat. 79, 360–365.PubMedCrossRefGoogle Scholar
  16. LEROY J.G., HO M.W., McBRINN M.C., ZIELKE K., JACOT J. and O’BRIEN J.S. (1972): I-cell disease: Biochemical studies. Ped. Res. 6, 752–757.CrossRefGoogle Scholar
  17. LEROY J.G. and MARTIN J.J. (1975): Mucolipidosis II (I-cell disease): present status of knowledge. Birth Defects, Orig. art. series 11, 283–293.Google Scholar
  18. LEROY J.G. and VAN ELSEN A.F. (1975): Natural history of a Mucolipidosis. Twin girl discordant for ML III.Birth Defects. Orig. art. series 11, 325–334.Google Scholar
  19. LEROY J.G. and O’BRIEN J.S. (1976): Different residual activity of /3 -galactosidase in cultured fibroblasts. Clin. Genet. 9, 533–539.PubMedCrossRefGoogle Scholar
  20. LIGHTBODY J., WIESMANN U., HADORN B. and HERSCHKOWITZ N. (1971): I-cell disease: multiple lysosomal enzyme defect. Lancet 1, 451.PubMedCrossRefGoogle Scholar
  21. MAROTEAUX P. and LAMY M. (1966): La pseudopolydystrophie de Hurler. Presse med. 74, 2889–2892.Google Scholar
  22. MAROTFAUX P., POISSONIER M., TONDEUR M., STRECKER M. and LEUMONNIER M. (1978): Sialidose par déficit en oß(2–6) neuramini- dase sans atteinte neurologique. Arch. Fr. Pédiat. 35, 290–291.Google Scholar
  23. MARTIN J.J., LEROY J.G., FARRIAUX J.P., FONTAINE G., DESNICK R.J. and CABELLO A. (1975): I-cell disease (Mucolipidosis II). A report on its Pathology. Acta neuropath. 33, 285–305.PubMedCrossRefGoogle Scholar
  24. MATSUDA I., ARASHIMA S., MITSUYAMA T., OKA Y., IKENCHI T., KANEKO Y., ISHIKAWA M. (1975): Prenatal diagnosis of I-cell disease. Humangenetik 30, 69–73.PubMedCrossRefGoogle Scholar
  25. NAGASHIMA K., SAKAKIBARA K., ENDO H., KONISHI Y., NAKAMURA N., SUZUKI Y. and ABE T. (1977): I-cell disease (mucolipidosis II) pathological and biochemical studies of an autopsy case. Acta Path. Jap. 27, 255–264.Google Scholar
  26. NOLTE K. and SPRANGER J. (1976): Early skeletal changes in Mucolipidosis III. Ann. Radiol. 19, 151–159.PubMedGoogle Scholar
  27. ORII T., MINAMI R., SUKEGAWA K., SATO S., TSUGAWA S., HORINO K., MIURA R. and NAKAO T. (1972): A new type of mucolipidosis with ~9 -galactosidase deficiency and glycopeptiduria. Tokoku J. Exp. Med. 107, 303–315.CrossRefGoogle Scholar
  28. PATRIQUIN H.B., KAPLAN P., KIND H.P. and GIEDION A. (1977): Neonatal mucolipidosis II (I-cell disease): clinical and radiological features in 3 cases. Am. J. Roentgenol. 129, 37–43.Google Scholar
  29. REITHER M., ZIMMERMANN G., GEHLER J., GATHMANN H. and TULUSAN H. (1977): Mucolipidosis II. Paediat. Praxis 18, 601–608.Google Scholar
  30. SPRANGER J., WIEDEMANN H.R., TOLKSDORF M., GRAUCOB E. and CAESAR R. (1968): Lipomucopolysaccharidose. Z. Kinderheilk. 103, 285–306.CrossRefGoogle Scholar
  31. SPRANGER J.W. and WIEDEMANN H.R. (1970): The genetic mucolipidoses. Dianosis and differential diagnosis. Human. Genet. 9, 113–139.CrossRefGoogle Scholar
  32. SPRANGER J. (1975): Mucolipidosis I. Birth Defects. Orig. arts, series 11, 279–282.Google Scholar
  33. SPRANGER J., GEHLER J. and CANTZ M. (1977): Mucolipidosis I. - A Sialidosis. Amer. J. Med. Genetic 1, 21–29.CrossRefGoogle Scholar
  34. STRECKER G., HONDI-ASSAH T., FOURNET B., SPIK G., MONTREUIL J., MAROTEAUX P., DURAND P. and FARRIAUX J.P. (1976): Structure of 3 major sialyloligosaccharides excreted in the urine of 5 patients with three distinct inborn diseases. I-cell disease and two new types of Mucolipidosis.Biochem. Biophys. Acta 444, 349–358.PubMedCrossRefGoogle Scholar
  35. STRECKER G., PEERS M.C., MICHALSKI J.C., HODNI ASSAH T., FOURNET B., SPIK G., MONTREUIL J., FARRIAUX J.P., MAROTEAUX P. and DURAND P. (1977): Structure of nine sialyloligosaccharides accumulated in urine of eleven patients with three different types of sialidosis. Europ. J. Biochem. 75, 391–403.PubMedCrossRefGoogle Scholar
  36. SUZUKI Y., FUKUOKA K., WEY J.J. and HANDA S. (1977): Betagalactosidase in mucopolysaccharidoses and mucolipidoses. Deficiency of GM1 beta-galactosidase in liver and leukocytes. Clin. Chim. Acta 75, 91–97.PubMedCrossRefGoogle Scholar
  37. THOMAS G.H., TAYLOR H.A., REYNOLDS L.W. and MILLER C.S. (1973): Mucolipidosis III (Pseudo-Hurler polydystrophy). Multiple lysosomal enzyme abnormalities in serum and cultured fibroblast cells. Ped. Res. 7, 751–756.CrossRefGoogle Scholar
  38. THOMAS G.H., TILLER G.E., REYNOLDS L.W., MILLER C.S. and BACE J.W. (1976): Increased levels of sialic acid associated with a sialidase deficiency in I-cell disease (Mucolipidosis II) fibroblasts. Biochem. Biophys. res. Commun. 71, 88–95.CrossRefGoogle Scholar
  39. VLADUTIU G.D. and RATTAllI M.C. (1975): Abnormal lysosomal hydro-lases excreted by cultured fibroblasts in I-cell disease (Mucolipidosis II). Biochem. Biophys. Res. Commun. 67, 956–964.PubMedCrossRefGoogle Scholar
  40. WARREN R.J. (1973): Antenatal diagnosis of mucolipidosis II (I-cell disease). Ped. Res. 7, 343–349.Google Scholar
  41. WIESMANN U.N., LIGHTBODY J., VASSELLA F. and HERSCHKOWITZ N. (1971a): Multiple lysosomal enzyme deficiency due to enzyme leakage? New Engl. J. Med. 284, 109.Google Scholar
  42. WIESMANN U.N., VASSELLA F. and HERSCHKOWITZ N. (1971b). I-cell disease: leakage of lysosomal enzymes into extracellular fluids. New Engl. J. Med. 285, 1090.PubMedGoogle Scholar
  43. WIESMANN U.N., VASSELLA F. and HERSCHKOWITZ N. (1973): Mucolipidosis II ( I-cell disease ): A clinical and biochemical study. Acta Paediat. Scand. 63, 9–18.CrossRefGoogle Scholar
  44. WIESMANN U.N. and HERSCHKOWITZ N. (1974): Studies on the pathogenetic mechanism of I-cell disease in cultured fibroblasts. Pediat. Res. 8, 865–870.PubMedCrossRefGoogle Scholar
  45. YAMAMOTO A., ADACHI S., KAWAMURA S., TAKAHASCHI M., KITANI T., OKTORI T., SHINJI Y. and NISHIKAWA M. (1974): Localized ß -galactosidase deficiency. Occurrence in cerebellar ataxia with myoclonus epilepsy and macular cherry red spot. A new variant of GM1-gangliosidosis. Arch. Intern. Med. 134, 627–631.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Ulrich N. Wiesmann
    • 1
  • Norbert Herschkowitz
    • 1
  1. 1.Department of PediatricsUniversity of BerneBernSwitzerland

Personalised recommendations